Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment

Overview
Details a simplified TIL production method using G-Rex®. G-Rex®10 is used for initial culture from tumor fragments/digests, and G-Rex®100 for rapid expansion (REP). This method reduces media use by 3-4 times and requires fewer vessels and labor compared to traditional 24-well plates and bags
What this paper found
Melanoma tumor infiltrating lymphocytes (TIL) can be initiated and rapidly expanded to treatment-scale numbers in gas-permeable G-Rex® flasks instead of 24-well plates, T-175 flasks and bags. In initial culture, G-Rex®10 flasks yielded TIL from 13 of 14 tumor digests with viability and CD3/CD8 phenotype similar to 24-well plates, and tumor fragments gave consistently higher yields per vessel. During rapid expansion, 5 × 10^6 TIL in a G-Rex®100 flask grew 176-fold in 7 days, versus 167-fold in T-175 flasks. A two-step 14-day process using TIL from 14 patients produced 8.60 ± 0.75 × 10^9 TIL per starting flask, a full-scale nine-flask run reached 23.6 × 10^9 cells, and interferon-γ release was similar to conventional cultures.
Note: In vitro process-development study using patient tumor samples; the authors note that G-Rex® flasks are not a closed system and that cells cannot be easily visualized.
These results suggest that TIL growth in G-Rex10 flasks is comparable with that in 24-well plates. — Jianjian Jin, Marianna Sabatino, Robert Somerville, John R. Wilson, Mark E. Dudley, David F. Stroncek, Steven A. Rosenberg, Journal of Immunotherapy
Study details
- Authors
- Jianjian Jin, Marianna Sabatino, Robert Somerville, John R. Wilson, Mark E. Dudley, David F. Stroncek, Steven A. Rosenberg
- Institution
- Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA · Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA · Wilson Wolf Manufacturing, New Brighton, MN, USA
- Journal
- Journal of Immunotherapy
- Year
- 2012
- G-Rex® model(s)
- G-Rex®10, G-Rex®100
- Cell type(s)
- TIL Cells
- Application area
- Solid tumor
- Study phase
- Preclinical
How G-Rex® was used
Initial TIL cultures were set up in G-Rex®10 flasks (10 cm² silicone bottom, about 40 mL) from tumor digests or from 5 to 30 tumor fragments per flask, and TIL were harvested after 7 to 29 days. For rapid expansion, G-Rex®100 flasks (100 cm², about 500 mL) were seeded with 5 × 10^6 TIL, irradiated PBMC feeders at 1:100, 3000 IU/mL IL-2 and 30 ng/mL anti-CD3 in 400 mL medium, split 1:3 into three flasks on day 7 and harvested on day 14. This gave a 176-fold expansion in 7 days. In clinical-scale runs, six G-Rex®10 flasks seeded with 5 fragments each fed 18 G-Rex®100 flasks.
Explore related
Full citation
Jin J, Sabatino M, Somerville R, et al. Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment. J Immunother. 2012;35(3):283-292.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.